4//SEC Filing
Sharei Armon 4
Accession 0000899243-21-009031
CIK 0001604477other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 5:32 PM ET
Size
7.2 KB
Accession
0000899243-21-009031
Insider Transaction Report
Form 4
Sharei Armon
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-02-27−8,000→ 195,986 totalExercise: $1.81Exp: 2026-10-10→ Common Stock (8,000 underlying) - Exercise/Conversion
Common Stock
2021-02-27$1.81/sh+8,000$14,480→ 259,713 total
Footnotes (2)
- [F1]Options were exercised and held for tax planning purposes.
- [F2]The option was originally granted for 286,514 shares. The option vested and became exercisable as to the original share amount as to 25% of the underlying securities on October 11, 2017 and in 36 equal monthly installments thereafter.
Documents
Issuer
SQZ Biotechnologies Co
CIK 0001604477
Entity typeother
Related Parties
1- filerCIK 0001829463
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 5:32 PM ET
- Size
- 7.2 KB